Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Charles

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Medical Journal of Australia|April 15, 2016
Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study)Jason A Trubiano, Rekha Pai Mangalore, Yi-Wei Baey, et al.
Journal of Clinical Microbiology|August 10, 2012
Buruli ulcer disease in travelers and differentiation of Mycobacterium ulcerans strains from northern AustraliaCaroline J Lavender, Maria Globan, Paul D R Johnson, et al.
Internal Medicine Journal|August 11, 2025
Effective real-world outcomes of remdesivir provided under compassionate access for moderate/severe COVID-19 in AustraliaRobert Stolz, Alice Liu, Jonathan Darby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2010
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiencyC L Gordon, P D R Johnson, M Permezel, et al.
Journal of Proteome Research|October 13, 2009
Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profileCarolyn M Slupsky, Kathryn N Rankin, Hao Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapyPatrick G P Charles, Michael Whitby, Andrew J Fuller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2008
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumoniaPatrick G P Charles, Rory Wolfe, Michael Whitby, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort studyVictoria G Hall, Beatrice Z Sim, Chhay Lim, et al.
Plos One|April 9, 2013
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniquesMaria A Said, Hope L Johnson, Bareng A S Nonyane, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Medical Journal of Australia|April 15, 2016
Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study)Jason A Trubiano, Rekha Pai Mangalore, Yi-Wei Baey, et al.
Journal of Clinical Microbiology|August 10, 2012
Buruli ulcer disease in travelers and differentiation of Mycobacterium ulcerans strains from northern AustraliaCaroline J Lavender, Maria Globan, Paul D R Johnson, et al.
Internal Medicine Journal|August 11, 2025
Effective real-world outcomes of remdesivir provided under compassionate access for moderate/severe COVID-19 in AustraliaRobert Stolz, Alice Liu, Jonathan Darby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2010
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiencyC L Gordon, P D R Johnson, M Permezel, et al.
Journal of Proteome Research|October 13, 2009
Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profileCarolyn M Slupsky, Kathryn N Rankin, Hao Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapyPatrick G P Charles, Michael Whitby, Andrew J Fuller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2008
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumoniaPatrick G P Charles, Rory Wolfe, Michael Whitby, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
COVID-19 infection among patients with cancer in Australia from 2020 to 2022: a national multicentre cohort studyVictoria G Hall, Beatrice Z Sim, Chhay Lim, et al.
Plos One|April 9, 2013
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniquesMaria A Said, Hope L Johnson, Bareng A S Nonyane, et al.
Pageof 5